Targeting Cancer with CRISPR/Cas9-Based Therapy.

Area of Science:

• Oncology
• Molecular Biology
• Gene Therapy

Background:

• Cancer is characterized by uncontrolled cell division and accumulating somatic mutations.
• Many cancer forms are resistant to current treatments.
• CRISPR/Cas9 technology allows precise targeting of genetic mutations.

Purpose of the Study:

• To review recent advancements in CRISPR/Cas9-based cancer-selective treatments.
• To highlight strategies for targeted delivery and controlled expression of CRISPR/Cas9.
• To discuss disrupting cancer-specific genes for selective malignant cell death.

Main Methods:

• Review of recent scientific literature on CRISPR/Cas9 applications in oncology.
• Focus on targeted delivery systems for CRISPR/Cas9 machinery.
• Strategies for controlling Cas9 expression in specific tissues.
• Methods for disrupting oncogenic mutations in cancer cells.

Main Results:

• CRISPR/Cas9 systems are being developed for precise targeting of oncogenic mutations.
• Strategies are emerging for cancer-selective delivery and controlled expression of CRISPR/Cas9.
• Disruption of cancer-specific genes can lead to selective death of malignant cells.
• Careful design is crucial to avoid off-target mutations and spare normal cells.

Conclusions:

• CRISPR/Cas9 gene editing holds significant potential for developing novel cancer therapies.
• Targeted delivery and controlled expression are key challenges for safe and effective clinical application.
• Future research should focus on optimizing these strategies for robust cancer treatment.